Time Is Money — And Preventable Delays Are Common India's Biological product approval timelines are frequently longer than companies anticipate. While CDSCO has made significant progress in recent years — introducing electronic...

Private equity investment in India's Pharmaceutical sector has accelerated substantially. The combination of a large domestic market, globally competitive manufacturing, and India's strategic position as a supplier of generic medicines to regulated...

India's Medical Device manufacturing sector is growing rapidly, driven by a combination of government policy, the Make in India initiative, and increasing global demand for cost-effective, high-quality medical products. For any company...

The Ingredient Compliance Imperative  For global Cosmetic brands, formulation approval in one major market — the EU, the US, or Japan is often viewed as a strong indicator of product safety and compliance. In India,...